Literature DB >> 33576454

Long non‑coding RNA ASAP1‑IT1 suppresses ovarian cancer progression by regulating Hippo/YAP signaling.

Ke Wang1, Yu-Bo Hu2, Ye Zhao3, Cong Ye1.   

Abstract

Long non‑coding RNAs (lncRNAs) are a class of non‑protein coding transcripts that are involved in the regulation of gene expression in mammalian cells. Transcriptional co‑activator Yes associated protein 1 (YAP1) plays a key role in the progression of ovarian cancer. However, the regulation of Hippo/YAP signaling in ovarian cancer remains elusive. In the present study, the expression levels of lncRNA ASAP1‑IT1 were investigated. The analysis indicated that lncRNA ASAP1‑IT1 expression was downregulated in ovarian tumor samples and ovarian cancer cells. The overexpression of ASAP1‑IT1 inhibited ovarian cancer cell proliferation and induced cell apoptosis. Bioinformatics analysis predicted that miR‑2278, a previously reported upregulated miRNA in ovarian tumors, may bind to ASAP1‑IT1. Dual luciferase assay confirmed the direct regulatory association between ASAP1‑IT1 and miR‑2278. In addition, the data demonstrated that large tumor suppressor 2 (LATS2) was a target gene of miR‑2278, whose expression was upregulated by ASAP1‑IT1 in ovarian cancer cells. By regulating the expression of LATS2, ASAP1‑IT1 induced the downregulation of YAP1 expression in ovarian cancer cells. Moreover, the silencing of LATS2 attenuated the inhibition of cell proliferation and the apoptosis induced by ASAP1‑IT1 overexpression in ovarian cancer cells. The association among the expression levels of ASAP1‑IT1, miR‑2278 and LATS2 was observed in specimens obtained from patients with ovarian cancer. Taken together, the data presented herein demonstrate that ASAP1‑IT1 functions as a potential tumor suppressor lncRNA by upregulating LATS2 expression in ovarian cancer.

Entities:  

Keywords:  ASAP1‑IT1; ovarian cancer; microRNA‑2278; Hippo/YAP signaling; large tumor suppressor 2

Mesh:

Substances:

Year:  2021        PMID: 33576454      PMCID: PMC7895538          DOI: 10.3892/ijmm.2021.4877

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  37 in total

1.  The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.

Authors:  Michelangelo Cordenonsi; Francesca Zanconato; Luca Azzolin; Mattia Forcato; Antonio Rosato; Chiara Frasson; Masafumi Inui; Marco Montagner; Anna R Parenti; Alessandro Poletti; Maria Grazia Daidone; Sirio Dupont; Giuseppe Basso; Silvio Bicciato; Stefano Piccolo
Journal:  Cell       Date:  2011-11-11       Impact factor: 41.582

2.  LncRNA ASAP1-IT1 positively modulates the development of cholangiocarcinoma via hedgehog signaling pathway.

Authors:  Linqi Guo; Yu Zhou; Ying Chen; Huawei Sun; Yue Wang; Yikun Qu
Journal:  Biomed Pharmacother       Date:  2018-04-24       Impact factor: 6.529

3.  Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts.

Authors:  Paola Todeschini; Elisa Salviato; Lara Paracchini; Manuela Ferracin; Marco Petrillo; Laura Zanotti; Germana Tognon; Angela Gambino; Enrica Calura; Giulia Caratti; Paolo Martini; Luca Beltrame; Lorenzo Maragoni; Daniela Gallo; Franco E Odicino; Enrico Sartori; Giovanni Scambia; Massimo Negrini; Antonella Ravaggi; Maurizio D'Incalci; Sergio Marchini; Eliana Bignotti; Chiara Romualdi
Journal:  Cancer Lett       Date:  2016-12-22       Impact factor: 8.679

4.  Long non-coding RNAs, ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer.

Authors:  Yuanyuan Fu; Nicoletta Biglia; Zhanwei Wang; Yi Shen; Harvey A Risch; Lingeng Lu; Emilie Marion Canuto; Wei Jia; Dionyssios Katsaros; Herbert Yu
Journal:  Gynecol Oncol       Date:  2016-09-23       Impact factor: 5.482

5.  Predicting effective microRNA target sites in mammalian mRNAs.

Authors:  Vikram Agarwal; George W Bell; Jin-Wu Nam; David P Bartel
Journal:  Elife       Date:  2015-08-12       Impact factor: 8.140

Review 6.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

7.  LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194.

Authors:  Jihong An; Weiling Lv; Yongzhou Zhang
Journal:  Onco Targets Ther       Date:  2017-11-10       Impact factor: 4.147

Review 8.  LncRNA-mediated regulation of cell signaling in cancer.

Authors:  W-X Peng; P Koirala; Y-Y Mo
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

9.  Silencing the long noncoding RNA, TINCR, a molecular sponge of miR‑335, inhibits the malignant phenotype of epithelial ovarian cancer via FGF2 suppression.

Authors:  Rui Li; Yue Wang; Yuexun Xu; Xiaoli He; Yali Li
Journal:  Int J Oncol       Date:  2019-09-10       Impact factor: 5.884

10.  Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.

Authors:  Huan Yan; Hong Li; Pengyun Li; Xia Li; Jianjian Lin; Linlin Zhu; Maria A Silva; Xiaofang Wang; Ping Wang; Zhan Zhang
Journal:  J Exp Clin Cancer Res       Date:  2018-09-24
View more
  5 in total

Review 1.  The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms.

Authors:  Yirao Zhang; Yang Wang; Hao Ji; Jie Ding; Keming Wang
Journal:  J Exp Clin Cancer Res       Date:  2022-06-14

Review 2.  The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers.

Authors:  Faiza Naz; Imran Tariq; Sajid Ali; Ahmed Somaida; Eduard Preis; Udo Bakowsky
Journal:  Cancers (Basel)       Date:  2021-12-03       Impact factor: 6.639

3.  Transcriptome-wide N6-methyladenine methylation in granulosa cells of women with decreased ovarian reserve.

Authors:  Chang Liu; Linshuang Li; Bo Yang; Yiqing Zhao; Xiyuan Dong; Lixia Zhu; Xinling Ren; Bo Huang; Jing Yue; Lei Jin; Hanwang Zhang; Lan Wang
Journal:  BMC Genomics       Date:  2022-03-28       Impact factor: 3.969

4.  Pathological significance and prognostic role of LATS2 in prostate cancer.

Authors:  Tsuyoshi Matsuda; Yasuyoshi Miyata; Yuichiro Nakamura; Asato Otsubo; Yuta Mukae; Junki Harada; Kensuke Mitsunari; Tomohiro Matsuo; Kojiro Ohba; Bungo Furusato; Hideki Sakai
Journal:  Prostate       Date:  2021-09-07       Impact factor: 4.012

5.  Identification of Characteristic Genes in Whole Blood of Intervertebral Disc Degeneration Patients by Weighted Gene Coexpression Network Analysis (WGCNA).

Authors:  Xiaobo Ma; Junqiang Su; Bo Wang; Xiasheng Jin
Journal:  Comput Math Methods Med       Date:  2022-01-13       Impact factor: 2.238

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.